OliX Pharmaceuticals, Inc (KOSDAQ:226950)
148,200
-3,000 (-1.98%)
May 20, 2026, 3:30 PM KST
225.00% (1Y)
| Market Cap | 3.01T +192.6% |
| Revenue (ttm) | 14.67B +158.3% |
| Net Income | -15.74B |
| EPS | -800.46 |
| Shares Out | 20.30M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 264,268 |
| Average Volume | 292,040 |
| Open | 147,500 |
| Previous Close | 151,200 |
| Day's Range | 140,700 - 154,400 |
| 52-Week Range | 34,500 - 217,000 |
| Beta | n/a |
| RSI | 39.37 |
| Earnings Date | Mar 27, 2026 |